Loading…
Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disorder. Cytokines contribute an important but yet undefined role to its pathogenesis. The present study aims to compare serum levels of cytokines involved in Th-1 and Th-2 immunity, such as interleukins (IL) IL-2, IL-4, IL-8, IL-10, inter...
Saved in:
Published in: | Respiratory medicine 2006-05, Vol.100 (5), p.938-945 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disorder. Cytokines contribute an important but yet undefined role to its pathogenesis.
The present study aims to compare serum levels of cytokines involved in Th-1 and Th-2 immunity, such as interleukins (IL) IL-2, IL-4, IL-8, IL-10, interferon-
γ (IFN-
γ) and IL-12 (p40) in patients with IPF and healthy volunteers. Twenty patients with IPF and 40 healthy controls (HC) participated.
Cytokines were assessed by enzyme-linked immunoabsorbent assay (ELISA).
Median values of serum IL-2, IL-8, IL-10, IL-12 (p40) were higher in the IPF than the control group: IPF group: 1.05
U/ml, 12.55, 10.13, 44.17
pg/ml; control group: 0.05
U/ml, 6.91, 0.75, 4.51
pg/ml, respectively
(
P
<
0.05
)
. IFN-
γ serum levels were lower in the IPF (0.19
pg/ml) than in the control group (0.49
pg/ml). IL-4 values did not differ in a statistically significant way among the groups: 8.40
pg/ml in the IPF group, and 7.46
pg/ml in the control group
(
P
>
0.05
)
. IL-4 positively correlated to fast expiratory volume in 1
s (FEV
1%) and forced vital capacity (FVC%), while IL-8 negatively correlated to the respective values
(
P
<
0.005
)
.
IL-2, IL-8, IL-10 and IL-12 (p40) were found to be elevated in the sera of patients with IPF. IFN-
γ was found to be decreased in the sera of patients with IPF. |
---|---|
ISSN: | 0954-6111 1532-3064 |
DOI: | 10.1016/j.rmed.2005.06.016 |